SCM
BNTC icon

Silverarc Capital Management’s Benitec Biopharma BNTC Stock Holding History

Silverarc Capital Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.64M Sell
717,725
-13,992
-2% -$162K 0.9% 33
2025
Q4 		$9.86M Buy
731,717
+455,450
+165% +$6.3M 1.43% 24
2025
Q3 		$3.88M Buy
276,267
+23,033
+9% +$294K 0.56% 50
2025
Q2 		$2.96M Buy
253,234
+3,234
+1% +$45.2K 0.61% 41
2025
Q1 		$3.25M Buy
+250,000
New +$3.02M 0.68% 43
2022
Q2 		– Sell
-28,993
Closed -$57 – 76
2022
Q1 		$57 Sell
28,993
-5,566
-16% -$231K 0.03% 66
2021
Q4 		$1.54M Buy
34,559
+5,264
+18% +$294K 0.69% 47
2021
Q3 		$1.78M Buy
29,295
+1,809
+7% +$119K 1.03% 35
2021
Q2 		$1.99K Buy
+27,486
New +$2.15M 0.97% 40

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $799M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return